Get the latest Science News and Discoveries
Intranasal COVID-19 vaccine headed to clinical trials - EurekAlert
University of Georgia-based startup CyanVac LLC received federal funding to support a comparative Phase 2b clinical trial of CVXGA, the company’s intranasal vaccine candidates designed to protect against COVID-19.
None
Or read this on Eureka Alert